NasdaqCM - Nasdaq Real Time Price USD

BioCardia, Inc. (BCDA)

1.9700
+0.0700
+(3.68%)
At close: May 23 at 4:00:01 PM EDT
2.0900
+0.12
+(6.09%)
After hours: May 23 at 5:22:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3
58
477
1,352
1,015
Cost of Revenue
--
--
--
--
0
Gross Profit
--
--
--
--
1,015
Operating Expense
8,455
8,059
12,121
13,253
13,645
Operating Income
-8,452
-8,001
-11,644
-11,901
-12,630
Net Non Operating Interest Income Expense
--
--
--
--
9
Other Income Expense
61
55
73
-6
7
Pretax Income
-8,391
-7,946
-11,571
-11,907
-12,623
Net Income Common Stockholders
-8,391
-7,946
-11,571
-11,907
-12,623
Diluted NI Available to Com Stockholders
-8,391
-7,946
-11,571
-11,907
-12,623
Basic EPS
-2.14
-2.90
-8.19
-10.05
-11.25
Diluted EPS
-2.14
-2.90
-8.19
-10.05
-11.25
Basic Average Shares
3,483.8840
2,743.8280
1,411.9980
1,181.3980
1,127.8440
Diluted Average Shares
3,483.8840
2,743.8280
1,411.9980
1,181.3980
1,127.8440
Total Operating Income as Reported
-8,452
-8,001
-11,644
-11,901
-12,630
Total Expenses
8,455
8,059
12,121
13,253
13,645
Net Income from Continuing & Discontinued Operation
-8,391
-7,946
-11,571
-11,907
-12,623
Normalized Income
-8,391
-7,946
-11,571
-11,907
-12,623
Interest Income
--
--
--
--
9
Interest Expense
--
--
--
--
0
Net Interest Income
--
--
--
--
9
EBIT
-8,452
-8,001
-11,644
-11,901
-12,630
EBITDA
-8,392
-7,934
-11,560
-11,819
-12,570
Reconciled Cost of Revenue
--
--
--
--
0
Reconciled Depreciation
60
67
84
82
60
Net Income from Continuing Operation Net Minority Interest
-8,391
-7,946
-11,571
-11,907
-12,623
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
-8,392
-7,934
-11,560
-11,819
-12,570
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/13/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LIXT Lixte Biotechnology Holdings, Inc.
1.3200
+3.13%
 
YMAB Y-mAbs Therapeutics, Inc.
4.3200
+4.60%
 
INAB IN8bio, Inc.
0.1449
+9.11%
 
ABOS Acumen Pharmaceuticals, Inc.
1.0200
-0.97%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5400
-1.41%
 
PHGE BiomX Inc.
0.5186
-1.97%
 
KTTA Pasithea Therapeutics Corp.
0.9153
-2.73%
 
ATNF 180 Life Sciences Corp.
0.9421
-8.53%
 
NTHI NeOnc Technologies Holdings, Inc.
7.22
-1.50%
 
SABS SAB Biotherapeutics, Inc.
1.8100
-2.69%